CZ  |  EN  |  SK

VivaBioCell was created in 2004 with the idea of prompting innovation in the field of cell culturing.  After the acquisition by ImmunityBio Inc., VivaBioCell has evolved, delivering several projects in the field of tissue engineering and cell cultures automation, aimed at the development of new clinical applications. The company strives to provide cost-effective solutions improving standardization in Advanced Therapies manufacturing.

Vision

VivaBioCell’s vision is to inspire the diffusion of Advanced Therapies bridging regenerative medicine into mainstream clinical practice. From a concept, towards the design and realization of new products – their main focus is on developing next-generation cell and immunotherapy solutions.

Quality and Compliance

VivaBioCell continuously strives to implement a certified quality management system to ensure the quality of the products and services and is certified ISO 9001:2015 by Kiwa, a world top 20 leader in testing, inspection and certification.